Riddlesworth, T
Thats exactly who should be getting this therapy. Targeting Alstrm Syndrome In Effectiveness of the Dual GIP/GLP1-Agonist Tirzepatide in 2 Cases of Alstrm Syndrome, a Rare Obesity Syndrome , published in JCEM in April, Thomas Scherer, MD, of the Medical University of Vienna, in Vienna, Austria, and team showed tirzepatides efficacy even in the particularly difficult-to-treat Alstrm syndrome (AS), a rare, genetic, multisystemic disorder, characterized by, among other conditions, diabetes with profound insulin resistance due to marked hyperphagia
This guide walks through how each option works, safety and effectiveness, cost and convenience, and when a telehealth program like Independent Wellness makes sense
"The goal of supplementation isn't just to consume nutrients, but to ensure those nutrients reach the cells where they are needed most." If you are ready to refine your daily routine, we recommend taking the Health Quiz